Database

Startups

Main Industry
Biotechnology
Main Product/Service
1. Development of botanical new drug
2. Certificated TAF testing service
Founded Year
2016
Unified Business No.
42861402
Status
Active
Number of Employees
16
Total Paid-in Capital
232,300,000 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
About the Company
BELX Biopharmaceuticals is an R&D oriented biotech company,focusing on developing botanical new drugs to treat tumors, infectious diseases, and aging-related chronicle diseases.



More ↓
Corporate Video

Similar Companies

EVERFRONT BIOTECH INC.

1. EF-001 (Cerebraca® Wafer)
2. EF-009 Wafer
3. HK-001
4. EF-031
5. TSCA-001
6. EF-011

ANYA BIOPHARM INC.

ORAL PEPTIDE
Summary of development timelines-product
MIRA/JE® Design
Lead Optimization
Preclinical Studies
Phase I
Phase II
Phase III
ANY002 Oral GLP1 product A: Prototype with human PK results available
ANY004 Oral GLP1 product B: Prototype in animal st